Shuttle Pharmaceuticals Holdings, Inc.
SHPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001757499
In the last 90 days, Shuttle Pharmaceuticals Holdings, Inc. insiders filed 2 open-market purchases and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $338.2K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Shuttle Pharmaceuticals Holdings, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 2 | 5 | +3 |
| Shares | 252.8K | 259.4K | +6.62K (+2.6%) |
| Value | $290.7K | $158.3K | −$132.5K (−45.6%) |
New holders (3)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 36,957 | $22.5K | 0.00% |
| Tower Research Capital LLC (TRC) | 103 | $63 | 0.00% |
| Wells Fargo & Company | 46 | $28 | 0.00% |
Sold out (0)
Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.